Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.36 EUR
1.16 B EUR
76.47 B EUR
1.34 B
About SINOPHARM GROUP CO. LTD.
Sector
Industry
Headquarters
Shanghai
Website
Founded
2003
ISIN
CNE100000FN7
FIGI
BBG000VZC619
Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Curated watchlists where X2S is featured.
Frequently Asked Questions
The current price of X2S is 2.45 EUR — it has increased by 1.11% in the past 24 hours. Watch SINOPHARM GROUP CO LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange SINOPHARM GROUP CO LTD stocks are traded under the ticker X2S.
X2S stock has risen by 1.07% compared to the previous week, the month change is a 6.94% rise, over the last year SINOPHARM GROUP CO LTD has showed a 8.07% increase.
We've gathered analysts' opinions on SINOPHARM GROUP CO LTD future price: according to them, X2S price has a max estimate of 3.41 EUR and a min estimate of 1.78 EUR. Watch X2S chart and read a more detailed SINOPHARM GROUP CO LTD stock forecast: see what analysts think of SINOPHARM GROUP CO LTD and suggest that you do with its stocks.
X2S stock is 1.10% volatile and has beta coefficient of 0.94. Track SINOPHARM GROUP CO LTD stock price on the chart and check out the list of the most volatile stocks — is SINOPHARM GROUP CO LTD there?
Today SINOPHARM GROUP CO LTD has the market capitalization of 7.71 B, it has increased by 2.40% over the last week.
Yes, you can track SINOPHARM GROUP CO LTD financials in yearly and quarterly reports right on TradingView.
SINOPHARM GROUP CO LTD is going to release the next earnings report on Mar 21, 2025. Keep track of upcoming events with our Earnings Calendar.
X2S earnings for the last half-year are 0.15 EUR per share, whereas the estimation was 0.18 EUR, resulting in a −13.77% surprise. The estimated earnings for the next half-year are 0.19 EUR per share. See more details about SINOPHARM GROUP CO LTD earnings.
SINOPHARM GROUP CO LTD revenue for the last half-year amounts to 37.85 B EUR, despite the estimated figure of 40.02 B EUR. In the next half-year revenue is expected to reach 40.21 B EUR.
X2S net income for the last half-year is 479.74 M EUR, while the previous report showed 620.23 M EUR of net income which accounts for −22.65% change. Track more SINOPHARM GROUP CO LTD financial stats to get the full picture.
Yes, X2S dividends are paid annually. The last dividend per share was 0.11 EUR. As of today, Dividend Yield (TTM)% is 4.71%. Tracking SINOPHARM GROUP CO LTD dividends might help you take more informed decisions.
SINOPHARM GROUP CO LTD dividend yield was 4.67% in 2023, and payout ratio reached 29.82%. The year before the numbers were 4.54% and 28.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 1, 2024, the company has 115.96 K employees. See our rating of the largest employees — is SINOPHARM GROUP CO LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SINOPHARM GROUP CO LTD EBITDA is 3.24 B EUR, and current EBITDA margin is 4.38%. See more stats in SINOPHARM GROUP CO LTD financial statements.
Like other stocks, X2S shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SINOPHARM GROUP CO LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SINOPHARM GROUP CO LTD technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SINOPHARM GROUP CO LTD stock shows the neutral signal. See more of SINOPHARM GROUP CO LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.